Terms: = Sarcomas AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Prognosis
58 results:
1. Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma.
Yang YT; Engleberg AI; Yuzbasiyan-Gurkan V
Cells; 2023 Dec; 13(1):. PubMed ID: 38201229
[TBL] [Abstract] [Full Text] [Related]
2. PROGNOSTIC IMPLICATIONS OF PD-L1 EXPRESSION AND LOSS OF pten IN PATIENTS WITH RHABDOMYOSARCOMA, EWING'S SARCOMA AND OSTEOSARCOMA.
Abd Elmoneim HM; Huwait HF; Nafady-Hego H; Mohamed FA
Exp Oncol; 2023 Dec; 45(3):337-350. PubMed ID: 38186021
[TBL] [Abstract] [Full Text] [Related]
3. Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database.
Mochizuki T; Ikegami M; Akiyama T
Cancer Sci; 2024 Feb; 115(2):575-588. PubMed ID: 38115234
[TBL] [Abstract] [Full Text] [Related]
4. New emerging targets in osteosarcoma therapy: pten and PI3K/Akt crosstalk in carcinogenesis.
Sadrkhanloo M; Paskeh MDA; Hashemi M; Raesi R; Bahonar A; Nakhaee Z; Entezari M; Beig Goharrizi MAS; Salimimoghadam S; Ren J; Nabavi N; Rashidi M; Dehkhoda F; Taheriazam A; Tan SC; Hushmandi K
Pathol Res Pract; 2023 Nov; 251():154902. PubMed ID: 37922723
[TBL] [Abstract] [Full Text] [Related]
5. Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.
Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
[TBL] [Abstract] [Full Text] [Related]
6. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
7. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
Kitazawa S; Chiyoda T; Nakamura K; Sakai K; Yoshihama T; Nishio H; Kobayashi Y; Iwata T; Banno K; Yamagami W; Nishihara H; Aoki D
Int J Clin Oncol; 2023 Nov; 28(11):1554-1562. PubMed ID: 37574505
[TBL] [Abstract] [Full Text] [Related]
8. A Phase I/II Investigation of Safety and Efficacy of Nivolumab and
Gordon EM; Angel NL; Omelchenko N; Chua-Alcala VS; Moradkhani A; Quon D; Wong S
Anticancer Res; 2023 May; 43(5):1993-2002. PubMed ID: 37097693
[TBL] [Abstract] [Full Text] [Related]
9. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
Liao X; Lai J; Lin J; Zhang D
Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
[TBL] [Abstract] [Full Text] [Related]
10. PINK1 regulates apoptosis of osteosarcoma as the target gene of cisplatin.
Si Z; Shen Z; Luan F; Yan J
J Orthop Surg Res; 2023 Feb; 18(1):132. PubMed ID: 36823640
[TBL] [Abstract] [Full Text] [Related]
11. Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis.
Pala L; Bagnardi V; Tettamanzi F; Barberis M; Mazzarol G; Casali C; De Pas T; Pennacchioli E; Coppola S; Baldini F; Cocorocchio E; Ferrucci P; Patane' D; Saponara M; Queirolo P; Conforti F
Mol Diagn Ther; 2023 Jan; 27(1):5-13. PubMed ID: 36401787
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
Tsang JY; Shao Y; Poon IK; Ni YB; Kwan JS; Chow C; Shea KH; Tse GM
Pathology; 2022 Oct; 54(6):678-685. PubMed ID: 35691725
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-181a-5p Promotes Osteosarcoma Progression via pten/AKT Pathway.
Sun C; Chen C; Chen Z; Guo J; Yu ZH; Qian W; Ai F; Xiao L; Guo X
Anal Cell Pathol (Amst); 2022; 2022():3421600. PubMed ID: 35310933
[TBL] [Abstract] [Full Text] [Related]
14. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
[TBL] [Abstract] [Full Text] [Related]
15. Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma.
Kodama M; Shimura H; Tien JC; Newberg JY; Kodama T; Wei Z; Rangel R; Yoshihara K; Kuruma A; Nakae A; Hashimoto K; Sawada K; Kimura T; Jenkins NA; Copeland NG
Cancer Res; 2021 Nov; 81(21):5413-5424. PubMed ID: 34475109
[TBL] [Abstract] [Full Text] [Related]
16. Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.
Paulsson JO; Rafati N; DiLorenzo S; Chen Y; Haglund F; Zedenius J; Juhlin CC
J Clin Endocrinol Metab; 2021 Oct; 106(11):3265-3282. PubMed ID: 34171097
[TBL] [Abstract] [Full Text] [Related]
17. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
[TBL] [Abstract] [Full Text] [Related]
18. Rapid Response of a BRCA2/TP53/pten-Deleted Metastatic Uterine Leiomyosarcoma to Olaparib: A Case Report.
Pan M; Ganjoo K; Karam A
Perm J; 2021 May; 25():. PubMed ID: 33970096
[TBL] [Abstract] [Full Text] [Related]
19. pten in osteosarcoma: Recent advances and the therapeutic potential.
Zheng C; Tang F; Min L; Hornicek F; Duan Z; Tu C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188405. PubMed ID: 32827577
[TBL] [Abstract] [Full Text] [Related]
20. FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting pten activity.
Wu W; Jing D; Meng Z; Hu B; Zhong B; Deng X; Jin X; Shao Z
Theranostics; 2020; 10(6):2859-2871. PubMed ID: 32194840
[No Abstract] [Full Text] [Related]
[Next]
